Skip to content
newprotein.net Explore ingredients
Menu
Microbial cells in a big loop fermenter fed by methane or sugar with a bowl of pale protein powder and feed pellets

Fermentation-derived proteins

Single cell protein: nutrition, nucleic acids and rules

By the New Protein editorial team · Reviewed · 5 min read

Single cell protein from fungi, bacteria, yeast and algae: biomass composition, RNA reduction, digestibility, FDA no-questions letters, novel food rules.

Protein
40–50 %
Strong at
Water binding
Diet
Vegan
Allergens
None of the 14 major allergens
Group
Fermentation-derived proteins

What single cell protein is and how it is made

Single cell protein is protein-rich biomass from microorganisms, grown in fermenters and harvested as whole cells or cell fractions. Producers use bacteria, yeast, filamentous fungi and microalgae, feeding them carbohydrates, gases or side streams. The term covers feed ingredients, mycelium-based meat structure builders and bacterial protein powders, so the single cell protein label hides large differences.

Fungal biomass is the best documented in food. In one FDA record, a Fusarium venenatum culture grows by fermentation on a food-grade carbohydrate for up to 30 days. The medium is then rapidly heated to cut RNA below 2 percent and inactivate the organism, and the slurry is centrifuged into a paste of about 25 percent biomass.

Other organisms follow other routes. A 2026 review groups single cell proteins into bacterial, yeast, fungal and algal types, with examples such as Methylococcus capsulatus and Clostridium autoethanogenum used in feed studies, and notes that microbial single cell protein development is constrained by group-specific issues including nucleic acid reduction, toxin and contaminant control, and cell-wall-associated digestibility.

Single cell protein nutrition and composition

Composition depends on the organism and the process. Notified Fusarium venenatum protein is specified at 42 percent crude protein or more on a dry basis, with 25 to 35 percent total fibre, under 12 percent fat and under 5 percent ash. Another notice describes Neurospora crassa mycelium as 40 to 50 percent protein with about 30 percent fibre.

Fibre in these products is largely cell wall material. The review notes that mycelial morphology, cell wall composition and fibrous matrix contribute to texture, satiety and gut fermentation, as well as to protein supply. A third notice, for Fusarium compactum, describes an off-white to light yellow dough-like matter containing at least 43 percent protein.

Protein quality cannot be read from crude protein. The review states that the functional value of cell-derived proteins cannot be inferred from crude protein alone, and that cell walls can limit digestibility. Published digestibility-corrected scores are not yet standard for these ingredients, so buyers should ask for measured amino acid and digestibility data on the specific product.

Nucleic acids are the defining nutritional constraint. Microbial cells have high nucleic acid to biomass ratios compared with plant or animal cells, and dietary nucleic acids end up as purines and uric acid in humans. The review warns that excessive intake of nucleic-acid-rich biomass may raise uric acid and the risk of gout, so RNA limits appear in specifications.

Processing, RNA reduction and functionality

RNA reduction can be physical or chemical. The fungal notice uses controlled heat treatment of the fermentation medium to reach below 2 percent. The review describes alkali and salt treatments for yeast and bacteria, and warns that harsh alkaline heating caused significant losses of dry biomass and crude protein, a trade-off between nucleic acid reduction and yield.

Functionality depends on structure. Filamentous fungal biomass carries a fibrous matrix that gives bite and chew, which is why it is used in meat and seafood alternatives and blended products. Yeast and bacterial cell mass is finer and behaves more like a protein powder, with limited solubility unless the cells are broken or hydrolysed.

Storage and handling differ from dried proteins. The fungal protein paste in the FDA record has a shelf life of 12 months when frozen and 72 hours at 0 to 4 degrees Celsius, so supply chains need frozen logistics. Dried forms, such as a product described as 93 percent solids, are also notified, and suit dry blends and ambient distribution.

Flavour and colour are comparatively mild for filamentous fungi, giving off-white to light yellow material. Yeast and bacterial biomass can bring yeasty, savoury or sulphurous notes, and colour from pigments or media. Purification, washing and heat steps reduce those traits, while savoury applications make use of them as a flavour benefit.

Applications and uses

Meat analogues and hybrid products are the main applications. The Neurospora crassa notice covers use as an ingredient and source of protein at levels up to 90 percent in meat, poultry and seafood products and in their alternatives, and the Fusarium venenatum notice allows use up to 94 percent of the final food excluding meat, poultry and infant formula.

Dairy alternatives and snacks follow. The listed categories show how broad the permitted uses are, and the notices make clear that approval is product-specific. For formulators, the benefit is a whole-food-like protein with fibre, not an isolate, and the practical question is how to hide or exploit the cell wall texture in the final recipe.

Mycelium-based ingredients form a subgroup. The entries for mushroom root and mycoprotein describe whole-cut and paste products from filamentous fungi, while yeast protein covers a different organism class. Developers choose between them on texture, flavour, regulatory status and cost, rather than on protein percentage alone, and test each in the final recipe.

Regulatory pathways and safety

In the United States, single cell proteins are regulated through existing food or feed pathways. For human food they may be evaluated under the GRAS framework, and FDA may issue a no-questions letter, which is not approval. FDA closed GRN 000904 (2021), GRN 000945 (2022), GRN 001117 (2024) and GRN 001255 (2025) this way.

In the European Union, single cell proteins for human food are commonly evaluated under the Novel Food Regulation by EFSA’s panel if they were not consumed to a significant degree before 15 May 1997. Updated guidance requires information on identity, production process, composition, specifications, proposed uses and intake. Approvals apply to named products and conditions.

Singapore treats algae, fungi and other alternative proteins without a history of consumption as novel foods that must be assessed before sale. Some applicants have stopped evaluation: FDA ceased to evaluate several mycelial biomass notices at notifier request, including GRN 001152 and GRN 001220 for Pleurotus pulmonarius and GRN 001268 for Rhizomucor pusillus, which shows that the route is demanding.

Sourcing and supply

Supply is concentrated among companies that have built fermentation capacity and cleared at least one regulatory file. Because approvals are product-specific, a buyer should ask which notices or authorisations cover the exact organism, strain and process, and in which markets, before specifying the ingredient in any recipe or launch plan.

Specifications should state protein, fibre, fat, ash, RNA, moisture, heavy metals, mycotoxin results where relevant, microbiology and allergen statements. Ask about the feedstock, the production organism, the heat treatment and whether the product is a paste or a dried form. Request shelf-life data and written handling instructions for any frozen paste.

Trials should evaluate texture, flavour, colour and digestibility in the full formula. Compare the biomass with plant proteins such as pea protein at equal protein, measure RNA and fibre contributions per serving, and check that labels describe the ingredient accurately in each market, using the name accepted by the regulator.

Frequently asked questions

What is single cell protein?

It is protein-rich biomass from microorganisms such as bacteria, yeast, filamentous fungi and microalgae, grown by fermentation on a carbon and nitrogen source. The whole cell mass, or a fraction of it, is dried or pasted and used in food or feed.

How much protein does it contain?

It depends on the organism. Notified fungal mycelial biomass is specified at 42 percent crude protein or more on a dry basis in one notice and described as 40 to 50 percent protein with about 30 percent fibre in another.

Why are nucleic acids a problem?

Microbial cells have a high nucleic acid share. Dietary nucleic acids break down to purines and then uric acid, so excessive intake could raise uric acid and the risk of gout. Producers reduce RNA by heat treatment, and one notice specifies RNA below 2 percent.

How is it regulated in the US and EU?

In the United States there is no SCP-specific approval; ingredients go through GRAS notices and FDA may reply with no questions. In the EU, products without a significant consumption history before 15 May 1997 are assessed as novel foods by EFSA.

Which single cell proteins has FDA reviewed?

FDA had no questions about fungal protein from Fusarium sp. in GRN 000904 and GRN 000945, mycelial biomass of Neurospora crassa in GRN 001117 and of Fusarium compactum in GRN 001255. A heat-killed Xanthobacter biomass notice, GRN 001351, was pending at the last inventory update.